Yahoo · Aug 27, 2026
ZEISS debuts DORC EVA NEXUS for cataract surgery at ESCRS
| Carl Zeiss Meditec AG
OTC · CZMWY
Healthcare · Medical - Instruments & Supplies
$33.72
Up+$0.45 (+1.34%)
Updated Sep 19, 2026, 4:52 PM
SID Score
5.2/10
Composite research score
Smart Money
46/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
CZMWY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning CZMWY.
CZMWY research
Company profile and research snapshot.
CARL ZEISS MEDI UNSP/ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 9, 2026 | EQUITA SIM | Buy | — |
| Jul 7, 2026 | METZLER EQUITIES | Buy | — |
| Jun 7, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
| Jun 1, 2026 | EQUI.TS | Neutral | — |
| May 28, 2026 | METZLER EQUITIES | Hold | — |
No generated briefing is available yet.
Yahoo · Aug 27, 2026
| Carl Zeiss Meditec AG
SeekingAlpha · Aug 19, 2026
Carl Zeiss Meditec remains a Strong Buy despite prolonged challenges, with a revised price target of â¬65/share (ADR: $75.42). Read more on CZMWY stock here.
SeekingAlpha · Aug 11, 2026
Carl Zeiss Meditec AG (CZMWY) Q3 2026 Earnings Call August 5, 2026 8:00 PM EDTCompany ParticipantsSebastian Frericks - Director of Investor RelationsAndreas...
SeekingAlpha · Aug 6, 2026
2026-08-06. The following slide deck was published by Carl Zeiss Meditec AG in conjunction with their 2026 Q3 earnings call.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning CZMWY.